Certificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.3%1-day move

₹30.00

prior close

₹31.71

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0-3.4+1.3+3.0+3.0+2.7+3.3+2.5-1.5+4.2-8.4+15.7

Up moveDown movePending

AI summary

Pharmaids Pharmaceuticals has submitted the quarterly certificate required under SEBI's Depositories and Participants Regulations, 2018 for the quarter ended March 31, 2026. The certificate was issued by the company's Registrar and Share Transfer Agent, Venture Capital and Corporate Investments Private Limited. It confirms that all physical share certificates received for dematerialization were properly mutilated, cancelled, and the depositories (NSDL and CDSL) were updated as the registered owner within 15 days, as required by the rules. The company has filed this with BSE purely for regulatory record-keeping purposes.

Likely market impact

This is a routine, procedural compliance filing with no financial or operational impact on the company. Shareholders do not need to take any action, and the filing is unlikely to have any effect on the stock price.